CDK12 covalent inhibitors (Aurigene discovery technologies)

N/A

Report date: 2025/06/11 11:04:04
NME

Base Information

Drug NameCDK12 covalent inhibitors (Aurigene discovery technologies)
Drug Alias NameAU-14984AU-15451
ClassificationSmall molecules
Mechanisms of ActionCyclin-dependent kinase 12 inhibitorsAnticancer protein kinase inhibitors
TargetsCyclin-dependent kinase 12
Therapy Area/IndicationsTriple Negative Breast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAurigene Oncology Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAurigene Oncology Ltd
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A